PATENTS GRANTED AND PENDING#

WO2021028562#

Lipid signatures for determining the outcome of embryo implantation during in vitro fertilization, The present invention relates to new methods for predicting the outcome of in vitro fertilization (IVF) procedures, as well as selecting the subjects to undergo IVF treatments. It also relates to methods for selecting IVF treatments and decision-making in said treatments as well as wash solutions for use in the treatment of infertility.
ID Patent: PCT/EP2020/072846

WO2018007511#

Diagnostic methods based on lipid profiles, The present invention relates to methods for the diagnosis of NAFLD in a subject, and for the differential diagnosis of NASH or steatosis in a subject suffering from NAFLD, based on the determination in a sample of metabolic markers, particularly lipid metabolic markers.
ID Patent: EP16382320.6

WO2018007422#

Identification of human Non-Alcoholic Fatty Liver Disease (NAFLD) subtypes, The present invention is directed to a profiling method for subtypes in non- alcoholic fatty liver disease (NAFLD) patients and to diagnostic methods within those subtypes to discriminate non-alcoholic steatohepatitis (NASH) versus steatosis patients.
ID Patent: EP16382319.8

WO2017055397#

Metabolomic signature of diagnosis and disease progression in Non-Alcoholic Fatty Liver Disease (NAFLD), The present invention is directed to a diagnostic method for non-alcoholic fatty liver disease (NAFLD) and to a method for monitoring the progression of the disease based on the determination of the levels of different metabolites. The invention also provides a method for determining the efficacy of an NAFLD therapy and a method for identification of compounds suitable for the treatment of NAFLD.
ID Patent: EP15382477.6